Hubei Biocause Heilen Pharmaceutical Co., Ltd. (301211.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Hubei Biocause Heilen Pharmaceutical Co., Ltd.
Sector
Basic Materials
Industry
Chemicals
Employees
1012
First IPO Date
December 22, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Qun Liang | General Manager | 0 | 1971 |
| Chunli Yang | Executive Vice President & Director | 0 | 1970 |
| Jian Gao | Board Secretary | 0 | 1977 |
| Zhenghua Huang | Deputy General Manager | 0 | 1972 |
| Qianqian Guan | Deputy General Manager | 0 | 1983 |
| Ting Hao Yi | Financial Director | 0 | 1973 |
| Weihua Zhu | Deputy General Manager | 0 | 1967 |
| Kuili Zhang | Deputy General Manager | 0 | 1976 |
| Chun Hua Quan | Accounting Supervisor | 0 | N/A |
AD
Description
Hubei Biocause Heilen Pharmaceutical Co., Ltd. is a Chinese enterprise with diverse operations spanning the pharmaceutical, chemical, and new energy fuel sectors. Within its pharmaceutical segment, the company manufactures active pharmaceutical ingredients (APIs), various intermediates, and finished drug formulations. Furthermore, its chemical offerings include industrial products such as dimethyl ether gas and chloropropionyl chloride. The firm is headquartered in Jingmen, China.
AD
